Daclizumab phase II trial in relapsing and remitting multiple sclerosis: MRI and clinical results. Rose JW, Burns JB, Bjorklund J, Klein J, Watt HE, Carlson NG Neurology. 2007 Aug 21; 69(8):785-9. PMID: 17709711. Abstract CommentRecommendBookmarkWatch